|
HIRA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62592161956354E-12 |
| Normal-vs-Stage2 |
8.16539946768557E-10 |
| Normal-vs-Stage3 |
1.2718048836291E-11 |
| Normal-vs-Stage4 |
4.73954209212479E-13 |
| Stage1-vs-Stage2 |
8.687800E-01 |
| Stage1-vs-Stage3 |
2.682400E-01 |
| Stage1-vs-Stage4 |
2.943900E-03 |
| Stage2-vs-Stage3 |
4.968400E-01 |
| Stage2-vs-Stage4 |
5.777500E-03 |
| Stage3-vs-Stage4 |
3.724500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62470037423645E-12 |
| Normal-vs-AfricanAmerican |
2.18380868943768E-13 |
| Normal-vs-Asian |
9.61470000282461E-08 |
| Caucasian-vs-AfricanAmerican |
8.901400E-01 |
| Caucasian-vs-Asian |
9.863700E-02 |
| AfricanAmerican-vs-Asian |
1.106430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.16018306073329E-13 |
| Male-vs-Female |
7.460200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.66342503607575E-13 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
8.60422844084496E-14 |
| Normal-vs-Extreme_Obese |
3.56790000000107E-05 |
| Normal_Weight-vs-Extreme_Weight |
8.585600E-01 |
| Normal_Weight-vs-Obese |
3.323800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.438800E-01 |
| Extreme_Weight-vs-Obese |
1.650980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.498950E-01 |
| Obese-vs-Extreme_Obese |
4.385000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.14720000008195E-07 |
| Normal-vs-Age(41-60Yrs) |
7.21644966006352E-15 |
| Normal-vs-Age(61-80Yrs) |
4.32986979603811E-15 |
| Normal-vs-Age(81-100Yrs) |
6.51049991695629E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.018600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.506200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.738200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.628200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.989400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.518200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.63224989080391E-12 |
| Normal-VS-KIRP CIMP |
1.17520437825647E-11 |
| Normal-VS-Unclassified PRCC |
7.89809995183077E-09 |
| Type1 PRCC-VS-Type2 PRCC |
3.046600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.625000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.607000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.539600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.592400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.095600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.22124532708767E-15 |
| Normal-vs-N1 |
1.66200386786386E-13 |
| Normal-vs-N2 |
1.94389999985667E-07 |
| N0-vs-N1 |
3.089600E-01 |
| N0-vs-N2 |
1.928220E-01 |
| N1-vs-N2 |
4.299000E-01 |
|
|
